REMNIQ owner Contact Information online
from GENZYME CORPORATION
REMNIQ
US serial number:85164383
Application filling date:Oct. 29, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jun. 16, 2014
Publication date:Mar. 15, 2011
Abandoned date:Jun. 16, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Therapeutic antibodies for use as anti-lymphocytic agents
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:Therapeutic antibodies for use as anti-lymphocytic agents
Current owner owner name:GENZYME CORPORATION
Current owner owner address:Legal Department
500 Kendall Street
Cambridge,
MASSACHUSETTS
UNITED STATES
02142
Current owner legal entity type:CORPORATION
Current owner state or country:MASSACHUSETTS
Attorney name:Susan Upton Douglass
Attorney email:sdouglass@frosszelnick.com
Attorney docket number:GENZ 1304716
Attorney email authorized:Yes
Correspondent name address:Susan Upton Douglass
Fross Zelnick Lehrman and Zissu, P.C.
866 United Nations Plaza
New York,
NEW YORK
UNITED STATES
10017
Correspondent phone:212-813-5900
Correspondent email:sdouglass@frosszelnick.com
Correspondent fax:212-813-5901
Correspondent email authorized:Yes
Trademark staff tm attorney:HENRY, NAKIA D
Trademark staff law office assigned REMNIQ:LAW OFFICE 117
Latest trademarks
Popular owners
Glaxo Group Limited (174) JOHNSON & JOHNSON (136) Novartis AG (134) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (47) Bayer Aktiengesellschaft (44) SANOFI (43) Pfizer Inc. (41) Wyeth LLC (41) Bristol-Myers Squibb Company (35) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) S. C. Johnson & Son, Inc. (29) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 15, 2011 Mar. 08, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
